Multilevel analyses of on-demand medication data, with an application to the treatment of Female Sexual Interest/Arousal Disorder

被引:3
|
作者
Kessels, Rob [1 ]
Bloemers, Jos [1 ,2 ,3 ]
Tuiten, Adriaan [1 ]
van der Heijden, Peter G. M. [4 ,5 ]
机构
[1] Emot Brain BV, Almere, Flevoland, Netherlands
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands
[3] Univ Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands
[4] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands
[5] Univ Southampton, Dept Social Sci, Southampton, Hants, England
来源
PLOS ONE | 2019年 / 14卷 / 08期
关键词
REFLUX SYMPTOMS; EFFICACY; MODELS; AROUSAL; SAFETY;
D O I
10.1371/journal.pone.0221063
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data from clinical trials investigating on-demand medication often consist of an intentionally varying number of measurements per patient. These measurements are often observations of discrete events of when the medication was taken, including for example data on symptom severity. In addition to the varying number of observations between patients, the data have another important feature: they are characterized by a hierarchical structure in which the events are nested within patients. Traditionally, the observed events of patients are aggregated into means and subsequently analyzed using, for example, a repeated measures ANOVA. This procedure has drawbacks. One drawback is that these patient means have different standard errors, first, because the variance of the underlying events differs between patients and second, because the number of events per patient differs. In this paper, we argue that such data should be analyzed by applying a multilevel analysis using the individual observed events as separate nested observations. Such a multilevel approach handles this drawback and it also enables the examination of varying drug effects across patients by estimating random effects. We show how multilevel analyses can be applied to on-demand medication data from a clinical trial investigating the efficacy of a drug for women with low sexual desire. We also explore linear and quadratic time effects that can only be performed when the individual events are considered as separate observations and we discuss several important statistical topics relevant for multilevel modeling. Taken together, the use of a multilevel approach considering events as nested observations in these types of data is advocated as it is more valid and provides more information than other (traditional) methods.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] A Randomized Trial Comparing Mindfulness to Sex Education for the Treatment of Sexual Interest/Arousal Disorder
    Brotto, Lori
    [J]. INTERNATIONAL JOURNAL OF SEXUAL HEALTH, 2022, 34 : 184 - 185
  • [32] Difference or dysfunction?: Deconstructing desire in the DSM-5 diagnosis of Female Sexual Interest/Arousal Disorder
    Thomas, Emily J.
    Gurevich, Maria
    [J]. FEMINISM & PSYCHOLOGY, 2021, 31 (01) : 81 - 98
  • [33] Neutral endopeptidase inhibition: could it have a role in the treatment of female sexual arousal disorder?
    Angulo, Javier
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (01) : 48 - 50
  • [34] A Systematic Literature Review of Health-related Quality of Life Measures for Women with Hypoactive Sexual Desire Disorder and Female Sexual Interest/Arousal Disorder
    Lim-Watson, Michelle Z.
    Hays, Ron D.
    Kingsberg, Sheryl
    Kallich, Joel D.
    Murimi-Worstell, Irene B.
    [J]. SEXUAL MEDICINE REVIEWS, 2022, 10 (01) : 23 - 41
  • [35] Affective and Autonomic Responses to Erotic Images: Evidence of Disgust-Based Mechanisms in Female Sexual Interest/Arousal Disorder
    DePesa, Natasha S.
    Cassisi, Jeffrey E.
    [J]. JOURNAL OF SEX RESEARCH, 2017, 54 (07) : 877 - 886
  • [36] A multilevel structural equation model for assessing a drug effect on a patient-reported outcome measure in on-demand medication data
    Kessels, Rob
    Moerbeek, Mirjam
    Bloemers, Jos
    van der Heijden, Peter G. M.
    [J]. BIOMETRICAL JOURNAL, 2021, 63 (08) : 1652 - 1672
  • [37] The Sexual Interest and Desire Inventory-Female (SIDI-F): Item response analyses of data from women diagnosed with hypoactive sexual desire disorder
    Sills, T
    Wunderlich, G
    Pyke, R
    Segraves, RT
    Leiblum, S
    Clayton, A
    Cotton, D
    Evans, K
    [J]. JOURNAL OF SEXUAL MEDICINE, 2005, 2 (06): : 801 - 818
  • [38] Women's Endorsement of Different Models of Sexual Functioning Supports Polythetic Criteria of Female Sexual Interest/Arousal Disorder in DSM-5
    Brotto, Lori A.
    Graham, Cynthia A.
    Paterson, Laurel Q.
    Yule, Morag A.
    Zucker, Kenneth J.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2015, 12 (09): : 1978 - 1981
  • [39] Modeling and simulation of sexual activity daily diary data of patients with female sexual arousal disorder treated with sildenafil citrate (Viagra®)
    Claret, Laurent
    Cox, Eugene H.
    McFadyen, Lynn
    Pidgen, Alwyn
    Johnson, Patrick J.
    Haughie, Scott
    Boolell, Mitra
    Bruno, Rene
    [J]. PHARMACEUTICAL RESEARCH, 2006, 23 (08) : 1756 - 1764
  • [40] Modeling and Simulation of Sexual Activity Daily Diary Data of Patients with Female Sexual Arousal Disorder Treated with Sildenafil Citrate (Viagra®)
    Laurent Claret
    Eugene H. Cox
    Lynn McFadyen
    Alwyn Pidgen
    Patrick J. Johnson
    Scott Haughie
    Mitra Boolell
    Rene Bruno
    [J]. Pharmaceutical Research, 2006, 23 : 1756 - 1764